558 related articles for article (PubMed ID: 31806884)
1. Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets.
Bi J; Chowdhry S; Wu S; Zhang W; Masui K; Mischel PS
Nat Rev Cancer; 2020 Jan; 20(1):57-70. PubMed ID: 31806884
[TBL] [Abstract][Full Text] [Related]
2. Cancer metabolism as a central driving force of glioma pathogenesis.
Masui K; Cavenee WK; Mischel PS
Brain Tumor Pathol; 2016 Jul; 33(3):161-8. PubMed ID: 27295313
[TBL] [Abstract][Full Text] [Related]
3. Tumour immune landscape of paediatric high-grade gliomas.
Ross JL; Velazquez Vega J; Plant A; MacDonald TJ; Becher OJ; Hambardzumyan D
Brain; 2021 Oct; 144(9):2594-2609. PubMed ID: 33856022
[TBL] [Abstract][Full Text] [Related]
4. [Biomarkers of glioma: recent advance and potential applications].
Yu SZ; Wang Q
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
[No Abstract] [Full Text] [Related]
5. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
Wirsching HG; Weller M
Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
[TBL] [Abstract][Full Text] [Related]
6. Gliomas.
Lombardi G; Della Puppa A; Di Stefano AL; Pace A; Rudà R; Tabouret E; Zagonel V
Biomed Res Int; 2014; 2014():470523. PubMed ID: 25243142
[No Abstract] [Full Text] [Related]
7. The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.
Pinton L; Masetto E; Vettore M; Solito S; Magri S; D'Andolfi M; Del Bianco P; Lollo G; Benoit JP; Okada H; Diaz A; Della Puppa A; Mandruzzato S
J Immunother Cancer; 2019 Feb; 7(1):58. PubMed ID: 30813960
[TBL] [Abstract][Full Text] [Related]
8. Drug Repurposing of Metabolic Agents in Malignant Glioma.
Seliger C; Hau P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223473
[TBL] [Abstract][Full Text] [Related]
9. Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.
Li D; Patel CB; Xu G; Iagaru A; Zhu Z; Zhang L; Cheng Z
Front Immunol; 2020; 11():592389. PubMed ID: 33193439
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs might be promising biomarkers of human gliomas.
Wang H; Yuan X; Zhou Z; Hu J; Zhang T; Hu S; Luo J; Li X
Asian Pac J Cancer Prev; 2011; 12(4):833-5. PubMed ID: 21790212
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming in the pathogenesis of glioma: Update.
Masui K; Onizuka H; Cavenee WK; Mischel PS; Shibata N
Neuropathology; 2019 Feb; 39(1):3-13. PubMed ID: 30609184
[TBL] [Abstract][Full Text] [Related]
14. Low-grade gliomas: when and how to treat.
Omay SB; Piepmeier JM; Knisely JP
Hematol Oncol Clin North Am; 2012 Aug; 26(4):797-809. PubMed ID: 22794284
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for malignant glioma based on PTEN status.
Gonzalez J; de Groot J
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1767-79. PubMed ID: 18983237
[TBL] [Abstract][Full Text] [Related]
16. TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9.
Chao M; Liu N; Sun Z; Jiang Y; Jiang T; Xv M; Jia L; Tu Y; Wang L
Front Immunol; 2020; 11():592080. PubMed ID: 33613515
[TBL] [Abstract][Full Text] [Related]
17. Malignant gliomas in adults.
Wen PY; Kesari S
N Engl J Med; 2008 Jul; 359(5):492-507. PubMed ID: 18669428
[No Abstract] [Full Text] [Related]
18. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.
Waerzeggers Y; Ullrich RT; Monfared P; Viel T; Weckesser M; Stummer W; Schober O; Winkeler A; Jacobs AH
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S179-95. PubMed ID: 22433828
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system gliomas.
Reni M; Mazza E; Zanon S; Gatta G; Vecht CJ
Crit Rev Oncol Hematol; 2017 May; 113():213-234. PubMed ID: 28427510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
